Results 131 to 140 of about 621 (166)

S3821 Clinical Utility of PuraStat in the Management of Symptomatic Diversion Colitis

American Journal of Gastroenterology
Colin Ly, Megan Wachsmann, N. Enwerem
semanticscholar   +2 more sources

S3822 Purastat Hemostasis in Critically Ill Patients

American Journal of Gastroenterology
Varun Moktan, Jordan S. Woodard, Joseph Beets   +2 more
semanticscholar   +2 more sources

S3823 PuraStat Hemostasis in a Patient Requiring Long Term Anticoagulation

American Journal of Gastroenterology
Varun Moktan, Jordan S. Woodard, Joseph Beets   +2 more
semanticscholar   +2 more sources

INTERVENTION AND MANAGEMENT OF GASTRIC VARICEAL BLEEDING USING PURASTAT, A SYNTHETIC HEMOSTATIC GEL

Gastrointestinal Endoscopy
Constantine Fisher, Sriya Bhumi, Kamal M. Hassan, S. Kim, Syed Hussain, Gagan Verma   +5 more
semanticscholar   +2 more sources

Safety and feasibility of PuraStat^® in laparoscopic colorectal surgery (Feasibility study)

Minimally Invasive Therapy & Allied Technologies, 2020
Haemorrhage remains a major cause of morbidity and death in all surgical specialties. The aim of this study was to analyse the feasibility of PuraStat®, a new synthetic haemostatic device, made of self-assembling peptides in laparoscopic colorectal surgery.This was a prospective observational non-randomised study.
Monica, Ortenzi, Amyn, Haji
openaire   +2 more sources

Prophylactic use of Purastat in colon endoscopic resection: a prospective study of clinical and economic benefits

Endoscopy
E. Mastrorocco, S. Montori, H. Htet, E. Albéniz, P. Bhandari   +4 more
semanticscholar   +2 more sources

IP15-01 CYSTOSCOPIC APPLICATION OF A HAEMOSTATIC AGENT - RADA16 SELF-ASSEMBLING PEPTIDE (PURASTAT) FOR REFRACTORY HAEMATURIA FROM RADIATION CYSTITIS: A NOVEL SURGICAL TECHNIQUE

Journal of Urology
administered to 15 patients between Feb to Oct 2024. Median age was 75 (Range 54-91years) and median time from radiotherapy 7 years (1.5-17). All patients were male and had radiation therapy for prostate cancer (47% primary and 53% adjuvant/salvage ...
G. Werneburg, Michael Gross, Daniel Hettel, Madison Lyon, Stacy H Jeong, Sean T. McSweeney, Jacob Knorr, A. Adler, Thien Dang, P. Orji, Suruchi A. Ramanujan, Howard B Goldman, Aaron Miller, S. Vasavada   +13 more
semanticscholar   +1 more source

A 70 second video demonstrating the laser resection performed in Figure 1 including addition of Purastat

ASVIDE, 2019
Joseph B. Mc Loughlin, Katie E. O’Sullivan, Rachel H. Brown, Donna Eaton   +3 more
openalex   +2 more sources

FP30 Purastat in POEM: a novel approach to reducing post-operative pain and length of stay

Flash Presentations
Hein Htet, Asma Alkandari, Ahmed Albhandari, A. A. HAMED, Mostafa Ibrahim, Mohammad Fathi, Raed Alswait, Hazem Emam Amer, Richard Chin, Sharmila Subramaniam, Gaius Longcroft‐Wheaton, Pradeep Bhandari   +11 more
openalex   +2 more sources

Efficacy of a novel hemostatic peptide gel (PuraStat) in preventing bleeding after endoscopic resection of large gastrointestinal lesions: a case series study

ESGE Days 2024
P. Andreozzi, M. Diaferia, Elena Di Girolamo, Corrado Civiletti, Valentina D’Angelo, Valentina Tudisco, V. Lambiase, P. Marone, Mario De Bellis   +8 more
openalex   +2 more sources